- During the sixth wave of Covid-19, there has been a 233% rebound in new infections in Mexico.
- Due to the Christmas and New Year celebrations, the increase in cases is expected to continue to rise.
- Although various vaccines already exist to reduce the risk of serious conditions, new drugs are still required to support patients.
The world is about to celebrate three years since the start of the biggest health emergency of the last century. Since then, nothing has been the same and although most face-to-face activities have resumed, it in no way means that the pandemic is over. In fact, Mexico is currently facing the sixth wave of Covid-19 and although it is less lethal than the previous ones, the number of infections continues to increase.
The immediate future does not look favorable due to the Christmas and New Year parties. Naturally, most people plan to get together as a family to celebrate these dates. For the same reason, the consequences could be appreciated from the second week of January.
The new subvariants that predominate
And it is that in this winter season a wide diversity of Ómicron subvariants circulates, such as the XBB or “Nightmare” and the BQ.1 or “Perro del inferno”, which caused the country to have a 233% rebound in November. the contagions. A) Yes, In the accumulated up to December 5, there were 7.1 million positive cases of SARS-CoV-2 and more than 330,000 deaths throughout the pandemicaccording to data from the Ministry of Health (SSa).
“The pandemic is far from being declared over and yet the new subvariants are less deadly. They continue to translate into enormous human, social and economic costs. In this context, there is a growing consensus that vaccines will not prevent the spread of the disease, which is why medical alternatives are needed for patients at risk of hospitalization, as well as those already hospitalized. This without forgetting the people who suffer from Long Covid”, said Dr. Alessandro Gadotti, CEO of Cellvera in Mexico.
For this reason, the global pharmaceutical sector is in constant research to create medicines that help reduce the risk of the pandemic, which protect the population from the effects of the virus and prevent the development of the disease at a serious level. .
More pharmacological options are needed
According to specialists such as Alessandro Gadotti, the development and arrival of affordable medical alternatives to the population on a daily basis against Covid-19 is key in Mexico, especially since this type of solution is prescribed to a potential patient in the comfort of their home. , would help not only to improve the person’s health in a few days and lessen the sequelae, but would also reduce a possible hospital burden in the face of a drastic increase in new cases. Which is more than necessary in view of the challenges of the country’s public health system, which has already passed a severe test in recent years.
“Continuing with what the World Health Organization said, regarding the fact that no vaccine against Covid-19 and its variants is 100% effective, today more than ever it is necessary not only to continue with all preventive measures among the population and the same booster vaccination, but there is also the need to promote new effective and safe drugs that help us make the infections of the new subvariants more bearable, while we prepare for the epidemics of the future”.
Also read:
The 2 exclusive symptoms of the “Hellhound” Variant
Variant Xibalbá or BW.1 will predominate during the sixth wave of Covid-19: These are its characteristics
Hellhound, unofficial name of the new Covid variant for this reason